Details for New Drug Application (NDA): 080281
✉ Email this page to a colleague
NDA 080281 describes ORETON, which is a drug marketed by Schering and is included in two NDAs. Additional details are available on the ORETON profile page.
The generic ingredient in ORETON is methyltestosterone. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methyltestosterone profile page.
The generic ingredient in ORETON is methyltestosterone. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methyltestosterone profile page.
Summary for 080281
| Tradename: | ORETON |
| Applicant: | Schering |
| Ingredient: | methyltestosterone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 080281
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;BUCCAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
